Novartis India case to resume on Monday
The case Novartis is bringing challenging the legality of certain provisions in the Indian Patent Act will resume on Monday, after it had been adjourned following an illness suffered by the judge. In the meantime, it seems, the pharmaceutical…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.